The Board and CEO of Emotra AB hereby present the interim report for the first three months of 2020. 200529 Interim report Jan- March 2020
Emotra AB (publ) Interim report January 1 – March 31, 2020
read more
Claes Holmberg
Claim form concerning a disputed debt served on Emotra in the district court of Göteborg
Since the autumn of 2017, Emotra has been involved in a dispute with an Italian consultancy, ABC Form Srl. Semplificata (“ABC”), for work mainly performed by professor Marco Sarchiapone from 2014 to 2017. 200528 - Emotra - PM - Claim form served concerning...
Emotra is collaborating with RISE in the development of AI-based analysis of EDOR® test
The use of AI, or machine learning, for EDOR test has been identified as an important technical development area for our method. 200526 - Emotra - PM - Emotra is collaborating with RISE for EDOR test
How covid-19 is affecting Emotra’s operations
Many companies in the so-called life science sector have been affected by the ongoing pandemic, and Emotra is no exception. 200507 - Emotra - PM - Effects of Covid-19 on Emotra's operations
EMOTRA AB: Trade in subscription warrants on Spotlight Stock Market
In March 2020, EMOTRA AB (“Emotra”) carried out a rights issue of Units (where each unit comprises two (2) shares and (2) subscription warrants). This new issue was also open to the public. 200406 - Emotra- PM -Trade in subscription warrants on spotlight stock...
EMOTRA AB: Final day for trading in BTUs
In March 2020, EMOTRA AB (“Emotra”) carried out a rights issue of Units (where each unit comprises two (2) shares and (2) subscription warrants). .... 200403 - Emotra- PM - Final day for tradel in BTU
EMOTRA AB: Emotra has appointed Mangold Fondkommission as the liquidity guarantor for shares in the Company, listed on the Spotlight Stock Market
The purpose of a liquidity guarantor is to ensure market liquidity for a share and reduce the difference between buy and sell prices. This duty will commence on March 27, 2020. 200326 - Emotra- PM - Liquidity guarantor
Emotra has signed a collaboration agreement for clinical studies with Linköping University
Lately, Emotra has been focusing on the indication area depression relapse, with the goal of starting a clinical study in 2020. 200325 - Emotra - PM - Emotra signs collaboration agreement for clinical studies
EMOTRA AB: Results of the rights issue
On March 18, 2020, the subscription period for shares in EMOTRA AB’s (“EMOTRA” or “the Company”) rights issue, encompassing a maximum of 8,796,586 Units..... 200323 - Emotra- PM - Results of the rights issue
Emotra is close to sealing collaboration agreement for clinical studies
We are working to expand our portfolio and are close to achieving further milestones in our new indication area for EDOR® test – depression relapse. 200309 - Emotra - PM - Emotra close to sealing collaboration agreement for clinical studies